[
    [
        {
            "time": "",
            "original_text": "华泰证券(06886.HK)2021年公司债券(第二期)票面利率为3.42%",
            "features": {
                "keywords": [
                    "华泰证券",
                    "公司债券",
                    "票面利率",
                    "3.42%"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华泰证券(06886.HK)2021年公司债券(第二期)票面利率为3.42%",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华泰证券：新易盛（300502.SZ）毛利率呈现下滑趋势，下调至“增持”评级 盈利能力下降",
            "features": {
                "keywords": [
                    "华泰证券",
                    "新易盛",
                    "毛利率",
                    "下滑趋势",
                    "增持",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华泰证券：新易盛（300502.SZ）毛利率呈现下滑趋势，下调至“增持”评级 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "北京市天元律师事务所关于西安康拓医疗技术股份有限公司首次公开发行股票并在科创板上市战略配售专项核查的法律意见",
            "features": {
                "keywords": [
                    "北京市天元律师事务所",
                    "西安康拓医疗",
                    "首次公开发行",
                    "科创板",
                    "战略配售",
                    "法律意见"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "北京市天元律师事务所关于西安康拓医疗技术股份有限公司首次公开发行股票并在科创板上市战略配售专项核查的法律意见",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        }
    ]
]